Intracoronary Injection of Autologous CD34+ Cells Improves One-Year Left Ventricular Systolic Function in Patients with Diffuse Coronary Artery Disease and Preserved Cardiac Performance—A Randomized, Open-Label, Controlled Phase II Clinical Trial

This phase II randomized controlled trial tested whether intracoronary autologous CD34+ cell therapy could further improve left ventricular (LV) systolic function in patients with diffuse coronary artery disease (CAD) with relatively preserved LV ejection fraction (defined as LVEF >40%) unsuitabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Pei-Hsun, Li, Yi-Chen, Lee, Mel S., Hsiao, Hao-Yi, Ma, Ming-Chun, Pei, Sung-Nan, Chiang, Hsin-Ju, Lee, Fan-Yen, Yip, Hon-Kan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231253/
https://www.ncbi.nlm.nih.gov/pubmed/32272750
http://dx.doi.org/10.3390/jcm9041043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231253/
https://www.ncbi.nlm.nih.gov/pubmed/32272750
http://dx.doi.org/10.3390/jcm9041043

Ejemplares similares